Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy.

Reference
Kelly KR, Espitia CM, Zhao W, Wu K, Visconte V, Anwer F, Calton CM, Carew JS, Nawrocki ST. 2018. Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy. Leukemia. 32:230–233. doi:10.1038/leu.2017.272.